The AI-Driven Platform for
Translational Drug Development
Moir.Ai is operating at the intersection of artificial intelligence, data science, biology, and pharmaceutical development to translating data into smarter drug decisions.​
Our ambition is to transform the translational phase of new drug development by accelerating and streamlining it through a smarter and more ethical AI-driven, multi-objective optimization platform.
The challenge
Drug development faces high attrition, long timelines, and heavy reliance on animal testing with often limited translatability for predicting the therapeutic properties of drug candidates in humans.
​
Over 50% of drug candidates fail during translation from preclinical models to human clinical stages, creating not only delays therapeutic innovation but major ethical and economic hurdles.
Our mission
To transform translational medicine through AI, enabling safer and more effective treatments to reach patients faster while aligning with modern ethical standards.
​
Moir-Ai concentrates on translational decision-making and simultaneous optimization across key drug therapeutic objectives, helping pharma industry players to make better IND-enabling choices by providing a single and holistic view.
Our solution
Moir-Ai develops a translational AI-driven, multi-objective decision platform that integrates into pharma, biotech, and academic R&D processes to compare candidates, predict optimized therapeutic properties and translational performance to de-risk their preclinical-to-clinical transition.
By integrating multimodal data from preclinical and clinical sources, the platform supports decision-making to confidently select the most promising drug lead candidates, thereby reducing failures, timelines, costs, and animal testing.
Our team
Aurélie Olivier, PhD, Global Executive MBA
Founder & CEO of Moir-Ai
With over 15 years' experience in leadership roles in translational research and drug development, Aurélie is a scientist and biotech strategist who combines scientific expertise with business leadership. Passionate about innovation and AI in healthcare, she is bringing the scientific vision to reshape how drug candidates translate from bench to bedside using AI, and the business strategy to the Moir-Ai project.
Carrers
Join the founding team of Moir-Ai:
We are looking for a Co-Founder & CTO to shape the technical vision of Moir-Ai and co-build our AI-driven translational drug development platform. If you are passionate about AI for healthcare and ready to embark on a deep tech journey with strong societal impact, we want to hear from you.
Contact
Interested in learning more about the Moir-Ai’s AI-driven translational drug development platform or partnering on data and PoC studies?
We’d love to hear from you.
Let’s talk!